FDA to Host Virtual Events on Food Allergen Thresholds

WASHINGTON, D.C. – The U.S. Food and Drug Administration (FDA) will host a virtual public meeting on Nov. 18 and listening sessions on Nov. 19-20 regarding food allergen thresholds and their potential applications.

Recent scientific developments in food allergen thresholds have prompted the FDA to explore how these thresholds can improve food safety, enhance labeling practices and help consumers make more informed choices. The purpose of the public meeting and listening sessions is to discuss strategies for approaching food allergen thresholds to benefit public health.

During these events, presentations will provide background on the food allergen landscape and risk-based food allergen thresholds. The two days of facilitated listening sessions (Nov. 19-20) will offer participants the opportunity to provide feedback on the following topics:

• Risk-based food allergen thresholds concepts,
• Risk communications and labeling,
• Potential applications of food allergen thresholds; and
• Challenges with food allergen thresholds in the U.S.

Questions for consideration during the public meeting and listening sessions, should be submitted through the registration.

Registration for the Nov. 18 public meeting will remain open until the start of the meeting. In order to attend the listening sessions, participants are required to register by Nov. 3. There will be a maximum number of participants for each session.

Beginning Nov. 18, a Regulations.gov docket will open for comments related to the event topic. The FDA will provide future communications on the comments process and timeline.

More information about the public meeting is available on the meeting page.